Stanislav Emelianov
Contact
Molecular Science and Engineering (MoSE) Building, Room 4100MGeorgia TechBiography
Dr. Stanislav Emelianov is a Joseph M. Pettit Endowed Chair, Georgia Research Alliance Eminent Scholar, and Professor of Electrical & Computer Engineering and Biomedical Engineering at the Georgia Institute of Technology. He is also a Professor of Radiology & Imaging Sciences and is affiliated with Winship Cancer Institute and other clinical units at Emory University School of Medicine. Furthermore, Dr. Emelianov is Director of the Ultrasound Imaging and Therapeutics Research Laboratory at the Georgia Institute of Technology where projects are focused on the discovery, development and clinical translation of diagnostic imaging and therapeutic instrumentation, augmented with theranostic nanoagents.
Dr. Emelianov is a nationally recognized expert in biomedical imaging instrumentation and nanoagents for imaging and therapy. He is the author of over 250 archival publications including peer-reviewed research articles and invited reviews, and more than 500 proceedings, abstracts, and presentation. In recognition of his contributions to the field, Dr. Emelianov has been named a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), Institute of Electrical and Electronics Engineers (IEEE), Acoustical Society of America (OSA), and Society of Photographic Instrumentation Engineers (SPIE).
Education
- Ph.D. in Physics and Applied Math, 1992 - Moscow State University
- M.S in Physics and Acoustics, 1989 - Moscow State University
- B.S. in Physics and Math, 1986 - Moscow State University
Research Interests
Dr. Emelianov's research focuses on the discovery, development and clinical translation of diagnostic imaging and therapeutic instrumentation, augmented with theranostic nanoagents. Throughout his career, Dr. Emelianov has been at the forefront of advancing functional, cellular, and molecular imaging methods. These methods are designed to detect and diagnose various pathologies, particularly cancer, while aiding in treatment planning, improving image-guided therapy, and monitoring treatment outcomes.
